Search

• ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV

  Media

  Key abstracts to be presented at CROI 2024 by ViiV Healthcare and its study partners.

  https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-hiv/

  First published: 28 February 2024

• ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at EACS 2023

  Media

  Key data to be presented include long-term and real-world data, including long-acting and 2-drug regimens.

  https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-to-present-23-abstracts-from-innovative-hiv-treatment-and-prevention-portfolio-at-eacs-2023/

  First published: 18 October 2023

• GSK delivers sales of £7.7 billion +6% AER, +5% CER

  Media

  Total EPS 16.8p, +50% AER, +42% CER; Adjusted EPS 30.1p, +22% AER, +18% CER

  https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-sales-of-77-billion-plus6-aer-plus5-cer/

  First published: 01 May 2019

• GSK delivers Q2 sales of £7.6 billion -2% AER, -3% CER (Pro-forma -10% CER*)

  Media

  GSK delivers Q2 sales of £7.6 billion -2% AER, -3% CER (Pro-forma -10% CER*)

  https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-q2-sales-of-76-billion-2-aer-3-cer-pro-forma-10-cerstar/

  First published: 29 July 2020

• New GSK to deliver step-change in growth and performance over next ten years driven by high-quality Vaccines and Specialty Medicines portfolio and late-stage pipeline

  Media

  New GSK to positively impact health of >2.5 billion people next 10 years

  https://www.gsk.com/en-gb/media/press-releases/new-gsk-to-deliver-step-change-in-growth-and-performance-over-next-ten-years/

  First published: 23 June 2021

• GSK to present updates on its industry-leading infectious disease portfolio at IDWeek 2022

  Media

  GSK will share updates on its industry-leading infectious disease pipeline and portfolio with 33 abstracts accepted for IDWeek 2022.

  https://www.gsk.com/en-gb/media/press-releases/gsk-to-present-updates-on-its-industry-leading-infectious-disease-portfolio-at-idweek-2022/

  First published: 12 October 2022

• GSK and ViiV Healthcare to present scientific advancements in their industry-leading infectious diseases portfolio at IDWeek 2023

  Media

  First scientific presentation of RSV vaccine efficacy and safety data over two seasons.

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-viiv-healthcare-to-present-scientific-advancements-at-idweek-2023/

  First published: 10 October 2023